Citi Reiterates Buy Rating on Madrigal Pharmaceuticals (MDGL)
Go back to Citi Reiterates Buy Rating on Madrigal Pharmaceuticals (MDGL)| (NASDAQ: MDGL) | Delayed: 533.76 -9.93 (1.83%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $543.69 | 52 Week High | $18.24 | |||
| Open | $539.38 | 52 Week Low | $6.60 | |||
| Day High | $542.16 | P/E | N/A | |||
| Day Low | $528.29 | EPS | $0.00 | |||
| Volume | 268,665 | |||||

